Related Experiment Video

Updated: Apr 21, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

15.4K

In Silico Inhibition Studies of Jun-Fos-DNA Complex Formation by Curcumin Derivatives

Anil Kumar1, Utpal Bora2

  • 1Computational Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Guwahati, Assam, Guwahati 781039, India.

International Journal of Medicinal Chemistry
|November 7, 2014
PubMed

Insights

Curcumin derivatives show potential in inhibiting the Jun-Fos-DNA complex, a key factor in various cancers. Curcumin sulphate emerged as the most effective inhibitor in this in silico study, offering a promising cancer therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Computational Chemistry

Background:

  • Activator protein-1 (AP1), a transcription factor composed of Jun and Fos proteins, regulates critical cellular processes like proliferation and inflammation.
  • AP1 is constitutively active in several cancers, including breast, ovarian, cervical, and lung cancers, making it a target for cancer therapeutics.
  • Inhibition of AP1 is a recognized strategy for cancer treatment.

Purpose of the Study:

  • To investigate the potential of curcumin derivatives in inhibiting the formation of the Jun-Fos-DNA complex.
  • To identify specific interactions between curcumin derivatives and key amino acid residues in the AP1 binding site.
  • To evaluate the efficacy of natural curcumin derivatives as inhibitors of AP1 activity.

Main Methods:

  • In silico molecular docking studies were performed to analyze the interactions between Jun-Fos-DNA complex and curcumin derivatives.
  • Identification of critical amino acid residues (Arg155, Arg158) involved in the binding of the Jun-Fos complex to the AP1 DNA site.
  • Assessment of hydrophobic interactions between the binding site residues (Ala151, Ala275, Leu283, Ile286) and inhibitor molecules.

Main Results:

  • Curcumin derivatives were found to interact with key amino acid residues Arg155 and Arg158, crucial for Jun-Fos-DNA binding.
  • Specific hydrophobic contacts were observed between the binding site residues (Ala151, Ala275, Leu283, Ile286) and the docked curcumin derivatives.
  • Curcumin sulphate was identified as the most potent inhibitor among the tested natural curcumin derivatives.

Conclusions:

  • Curcumin derivatives can effectively inhibit the Jun-Fos-DNA complex formation by interacting with critical binding site residues.
  • The findings suggest that curcumin derivatives, particularly curcumin sulphate, hold promise as novel therapeutic agents for AP1-driven cancers.
  • This in silico study provides a foundation for further experimental validation of curcumin derivatives as cancer therapeutics.

More Related Videos

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

696
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

12.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.7K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
97
In vitro Mutagenesis01:16

In vitro Mutagenesis

5.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.7K